Complete financial analysis of Medivir AB (publ) (MVIR-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medivir AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Brookfield Reinsurance Ltd. (BAMR) Income Statement Analysis – Financial Results
- Analog Integrations Corporation (6291.TWO) Income Statement Analysis – Financial Results
- Kwan On Holdings Limited (1559.HK) Income Statement Analysis – Financial Results
- TechnoPlus Ventures Ltd. (TNPV.TA) Income Statement Analysis – Financial Results
- Collector Bank AB (COLL.ST) Income Statement Analysis – Financial Results
Medivir AB (publ) (MVIR-B.ST)
About Medivir AB (publ)
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.41M | 25.54M | 13.95M | 8.72M | 23.86M | 36.64M | 93.04M | 657.89M | 1.77B | 446.15M | 555.03M | 698.57M | 57.29M | 35.50M | 101.98M | 253.46M | 129.34M | 104.86M | 85.11M | 152.62M | 259.42M | 126.90M |
| Cost of Revenue | 69.08M | 73.28M | 52.93M | 91.06M | 0.00 | 0.00 | 15.95M | 109.28M | 174.02M | 71.77M | 402.67M | 240.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.70M | 63.44M | 53.79M |
| Gross Profit | -64.67M | -47.74M | -38.98M | -82.34M | 23.86M | 36.64M | 77.09M | 548.61M | 1.59B | 374.38M | 152.36M | 457.95M | 57.29M | 35.50M | 101.98M | 253.46M | 129.34M | 104.86M | 85.11M | 118.92M | 195.98M | 73.11M |
| Gross Profit Ratio | -1,467.11% | -186.93% | -279.50% | -943.82% | 100.00% | 100.00% | 82.86% | 83.39% | 90.15% | 83.91% | 27.45% | 65.56% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 77.92% | 75.54% | 57.61% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 307.09M | 278.38M | 245.75M | 229.43M | 203.35M | 184.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 73.28M | 52.93M | 91.06M | 235.13M | 281.11M | 70.66M | 60.33M | 62.52M | 51.87M | 64.46M | 47.16M | 90.39M | 92.65M | 0.00 | 1.17M | 1.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.01M | 98.36M | 103.58M | 70.49M | 69.71M | 95.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.74M | 73.28M | 52.93M | 91.06M | 235.13M | 281.11M | 83.67M | 158.68M | 166.10M | 122.35M | 134.18M | 142.34M | 90.39M | 92.65M | 0.00 | 1.17M | 1.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 93.02M | 16.66M | 16.70M | 43.64M | 139.76M | 118.36M | -1.29M | -3.22M | -7.61M | -2.57M | 619.00K | 19.69M | 103.63M | 82.66M | 215.71M | 276.69M | 300.15M | 206.88M | 210.08M | 231.22M | 266.56M | 226.00M |
| Operating Expenses | 93.02M | 89.94M | 69.63M | 134.70M | 374.89M | 399.47M | 389.47M | 433.84M | 404.24M | 349.21M | 338.15M | 346.10M | 194.02M | 175.31M | 215.71M | 277.86M | 301.39M | 206.88M | 210.08M | 231.22M | 266.56M | 226.00M |
| Cost & Expenses | 93.02M | 89.94M | 69.63M | 134.70M | 374.89M | 399.47M | 405.42M | 543.12M | 578.26M | 420.98M | 740.82M | 586.72M | 194.02M | 175.31M | 215.71M | 277.86M | 301.39M | 206.88M | 210.08M | 264.91M | 330.00M | 279.79M |
| Interest Income | 8.00K | 0.00 | 1.00K | 1.36M | 54.00K | 76.00K | 9.24M | 0.00 | 0.00 | 4.20M | 1.04M | 21.13M | 2.53M | 0.00 | 616.00K | 5.03M | 489.00K | 1.25M | 862.00K | 604.00K | 749.00K | 168.00K |
| Interest Expense | 928.00K | 950.00K | 547.00K | 1.32M | 15.00K | 67.00K | 2.40M | 1.45M | 1.56M | 2.13M | 7.71M | 12.12M | 33.00K | 0.00 | 14.33M | 177.00K | 689.00K | 9.59M | 13.19M | 70.18M | 7.11M | 13.65M |
| Depreciation & Amortization | 2.54M | 1.91M | 3.14M | 9.91M | 26.30M | 29.97M | 33.46M | 34.12M | 33.19M | 33.48M | 34.82M | 23.43M | 7.88M | 10.39M | 10.32M | 10.75M | 17.53M | 20.21M | 17.89M | 20.40M | 24.34M | 22.85M |
| EBITDA | -84.81M | -60.20M | -39.76M | -116.07M | -324.16M | -329.69M | 306.84M | 137.52M | 1.23B | 25.89M | -150.39M | 146.76M | -126.32M | -125.00M | -75.37M | -17.90M | -182.24M | -78.02M | -81.56M | 47.85M | -32.77M | -102.93M |
| EBITDA Ratio | -1,924.00% | -235.74% | -285.08% | -1,330.50% | -1,358.40% | -899.84% | 329.78% | 20.90% | 69.47% | 5.80% | -27.10% | 21.01% | -220.50% | -352.13% | -73.91% | -7.06% | -140.90% | -74.40% | -95.83% | 31.36% | -12.63% | -81.11% |
| Operating Income | -87.35M | -62.12M | -42.90M | -125.98M | -351.03M | -362.83M | -312.38M | 114.77M | 1.19B | 25.16M | -185.79M | 111.85M | -136.73M | -139.82M | -113.73M | -24.40M | -172.05M | -102.02M | -124.97M | -112.30M | -70.58M | -152.90M |
| Operating Income Ratio | -1,981.72% | -243.24% | -307.57% | -1,444.05% | -1,471.02% | -990.29% | -335.74% | 17.44% | 67.27% | 5.64% | -33.47% | 16.01% | -238.67% | -393.87% | -111.53% | -9.63% | -133.03% | -97.29% | -146.84% | -73.58% | -27.21% | -120.49% |
| Total Other Income/Expenses | -1.41M | -461.00K | 280.00K | 2.65M | 555.00K | 3.11M | 5.66M | -12.81M | 3.97M | 2.47M | -7.12M | -643.00K | 2.50M | 4.43M | 13.71M | -4.43M | -28.40M | 8.34M | 12.33M | 69.58M | 6.36M | 13.48M |
| Income Before Tax | -88.77M | -62.58M | -42.62M | -123.33M | -350.48M | -359.73M | -306.73M | 101.95M | 1.19B | 27.63M | -192.91M | 111.21M | -134.23M | -135.39M | -100.02M | -28.83M | -200.46M | -93.68M | -112.64M | -42.72M | -64.22M | -139.42M |
| Income Before Tax Ratio | -2,013.73% | -245.04% | -305.56% | -1,413.73% | -1,468.70% | -981.82% | -329.66% | 15.50% | 67.50% | 6.19% | -34.76% | 15.92% | -234.30% | -381.40% | -98.09% | -11.37% | -154.99% | -89.34% | -132.35% | -27.99% | -24.76% | -109.87% |
| Income Tax Expense | 456.00K | 546.00K | -1.57M | 106.00K | -161.00K | 490.00K | -11.87M | 26.86M | 59.97M | 11.62M | 26.17M | -2.55M | 2.53M | -13.00K | -820.00K | 487.00K | -4.88M | -3.23M | -2.01M | -2.41M | -4.42M | -3.63M |
| Net Income | -89.22M | -63.13M | -41.05M | -123.44M | -350.31M | -360.22M | 282.85M | 75.09M | 1.13B | -21.34M | -219.08M | 113.75M | -134.23M | -135.38M | -99.20M | -29.32M | -195.58M | -104.58M | -110.63M | -40.31M | -59.80M | -135.79M |
| Net Income Ratio | -2,024.07% | -247.18% | -294.29% | -1,414.95% | -1,468.02% | -983.15% | 304.00% | 11.41% | 64.11% | -4.78% | -39.47% | 16.28% | -234.30% | -381.36% | -97.28% | -11.57% | -151.22% | -99.73% | -129.99% | -26.42% | -23.05% | -107.01% |
| EPS | -1.60 | -1.20 | -1.39 | -4.17 | -12.01 | -13.47 | 8.62 | 2.12 | 29.75 | -0.56 | -5.76 | 3.12 | -4.46 | -4.84 | -3.54 | -1.29 | -9.22 | -4.93 | -6.26 | -2.53 | -4.31 | -8.85 |
| EPS Diluted | -1.60 | -1.20 | -1.39 | -4.17 | -12.01 | -13.43 | 8.60 | 2.10 | 29.48 | -0.56 | -5.76 | 3.12 | -4.46 | -4.84 | -3.54 | -1.29 | -9.22 | -4.93 | -6.26 | -2.53 | -4.31 | -8.85 |
| Weighted Avg Shares Out | 55.74M | 52.60M | 29.58M | 29.58M | 29.18M | 26.75M | 32.81M | 35.38M | 38.07M | 38.07M | 38.07M | 36.44M | 30.10M | 27.99M | 27.99M | 22.66M | 21.22M | 21.22M | 17.67M | 15.91M | 13.88M | 15.35M |
| Weighted Avg Shares Out (Dil) | 55.74M | 52.82M | 29.58M | 29.58M | 29.18M | 26.82M | 32.90M | 35.72M | 38.43M | 38.07M | 38.07M | 36.44M | 30.10M | 27.99M | 27.99M | 22.66M | 21.22M | 21.22M | 17.67M | 15.91M | 13.88M | 15.35M |
Source: https://incomestatements.info
Category: Stock Reports